Actualités

Only a few months ago, exploding missiles and drones were lighting up the skies above Dubai and Abu Dhabi, shutting the airspace for everyone and everything else.

Investing.com -- KeyBanc Capital Markets downgraded Nike to Sector Weight from Overweight, flagging a slower-than-expected turnaround, mounting headwinds in China and Europe, and a management transition that further clouds the near-term outlook.

Pfizer's CFO joins Nike, Wendy's hires Potbelly Sandwiches' CFO, Airwallex's new CFO boomerangs back to the company and more.

It could provide some important updates.

It once was as hot as Amazon and Apple. Now it’s one of the 10 worst-performing stocks in the S&P 500.

BNP Paribas analyst Laurent Vasilescu called a reported plan by Nike to bar key Chinese distributors from selling products online starting in 2027 a “strategic misstep.”

Investors will see if the company's "Win Now" campaign is taking hold.

Nike's revenue remains far ahead, but both brands show consistent seasonal patterns and stable margins in recent quarters.

A Hold is maintained ahead of Q4 earnings despite a tariff-refund EPS bump

Nike Inc. will release its fourth-quarter earnings report after the closing bell on Tuesday, June 30. Analysts expect the company to report quarterly earnings of 12 cents per share. That’s down from 14 cents per share in the year-ago period....

(Bloomberg) -- Moving from Pfizer Inc. to Nike Inc. may seem like an unusual career shift for a finance chief. For David Denton, it marks a return to the consumer sector after four years in pharmaceuticals.Most Read from BloombergInvestor Who Scored 900% Win in 2008 Crisis Has New Big Short BetGrand Ole Opry House Up For Sale by Owner Ryman HospitalityMicron Shares Soar After AI-Fueled Forecast Shatters ProjectionsStocks Slide as Wall Street Gets AI Wake-Up Call: Markets WrapStocks Erase Gains a

Get a deeper insight into the potential performance of Nike (NKE) for the quarter ended May 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.

David Denton will replace Matthew Friend, who will remain at the company until 4 September to assist with the handover.

7.50am: 3i reveals slower growth for Action 3i Group said its largest portfolio company, Action, remains on track for a good second quarter despite like-for-like sales growth slowing. Ahead of its annual general meeting on Thursday, the FTSE 100-listed private equity investor said European...

Nike (NKE) reached $41.82 at the closing of the latest trading day, reflecting a -1.32% change compared to its last close.

Incoming Nike CFO David Denton seen as a stage in its turnaround progress, while earnings call Tuesday could see interest on one-time tariff refund.

Nike named Pfizer’s former CFO David Denton as finance chief and reaffirmed guidance, but clearer evidence that the turnaround is working may still be several quarters away.

BNP analyst Laurent Vasilescu considers the risk for Nike if a media report is accurate about a plan to change distribution in China.

Nike could be the next company dropped from the given its low stock price—and that might allow Berkshire Hathaway to finally make it into the venerable index. S&P Dow Jones Indices, which oversees both the Dow industrials and S&P 500 index, said that Verizon is leaving in part because its low stock price–around $46—gave the company an “immaterial impact” on the price-weighted index. Verizon’s weighting was around 0.5%, while Goldman Sachs whose stock trades for nearly $1,100 a share, has the highest weighting in the index at around 13%.

The sports apparel giant is turning to new financial leadership as it looks to make more progress with its “Win Now” turnaround strategy.

Nike Inc (NYSE:NKE, XETRA:NKE) has announced that David Denton will join the company as executive vice president and chief financial officer effective August 17, succeeding Matthew Friend, who will remain with the company through September 4 to support the transition. According to the...

David Denton, who has led Pfizer's finances since 2022, will take over as Nike's chief financial officer on Aug. 17

Nike names David Denton, a former Pfizer and CVS Health executive, as its next chief financial officer, and provides updated guidance.

Wall Street stocks are expected to make a steadier start on Wednesday after a sharp technology-led sell-off in the previous two sessions, with investors now focused on Micron's earnings for clues about the health of the artificial intelligence boom. Nasdaq and S&P 500 futures were...

NIKE is set to announce its fourth-quarter earnings this month, and Wall Street expects the company’s EPS to decrease by double digits.

The FIFA World Cup and other major international football tournaments consistently act as powerful demand drivers for the global sports retail industry.

Nike (NYSE:NKE) has appointed David M. Denton as its incoming Chief Financial Officer. Denton, who has held senior finance roles at Pfizer and Lowe's, is set to succeed current CFO Matthew Friend. The transition comes as Nike continues a multiyear turnaround and addresses operational challenges and skepticism about its execution. Nike, a major global sportswear and footwear company, is in the middle of a turnaround that includes operational adjustments and a renewed focus on execution. The...

Nike announced a CFO transition and said fourth-quarter results remain on track, excluding a one-time tariff refund benefit.

David Denton will join Nike Inc. as executive vice president and chief financial officer on Aug. 17, succeeding Matthew Friend.

David Denton’s appointment, effective Aug. 17, comes as the company struggles to execute its turnaround.